Drug to Antibody Ratio Analysis of Brentuximab Vedotin in Monkey Plasma
Applications | 2024 | Agilent TechnologiesInstrumentation
LC/HRMS, LC/MS, LC/MS/MS, LC/TOF
IndustriesClinical Research
ManufacturerAgilent Technologies
Key wordsbrentuximab, dar, monkey, lba, adc, amu, deconvoluted, drug, counts, adcs, native, antibody, assaymap, agilent, bravo, vedotin, mass, payload, were, streptavidin, plasma, cartridges, intact, analysis, bioconfirm, workflow, assay, automation, denatured, masshunter, conjugates, conjugated, buffer, under, different, molecules, tof, conditioned, from, amador, evidentic, kenda, southernbiotech, gas, technologies, muhammed, naqvi, ngai, spectrum, average
Similar PDF
Characterization of Antibody‑Drug Conjugates Using 2D-LC and Native MS
2021|Agilent Technologies|Applications
Application Note Biopharma/Pharma Characterization of Antibody‑Drug Conjugates Using 2D-LC and Native MS Authors David L. Wong and Sarah M. Stow Agilent Technologies, Inc. Abstract Antibody drug conjugates (ADCs), which comprise a monoclonal antibody (mAb) conjugated to a small molecule drug…
Key words
dimension, dimensiondar, daradcs, adcsadc, adcsecond, secondnative, nativehic, hicadvancebio, advancebiocounts, countsmab, mabdrug, drugdeconvoluted, deconvolutedfirst, firstconjugated, conjugatedintact
Assessing Protein and Payload Stability of Antibody Drug Conjugate Brentuximab Vedotin in Monkey Plasma
2023|Agilent Technologies|Applications
Application Note Biotherapeutics & Biosimilars Assessing Protein and Payload Stability of Antibody Drug Conjugate Brentuximab Vedotin in Monkey Plasma Using Agilent AssayMAP Bravo and Agilent 6495 Triple Quadrupole LC/MS Systems Authors Xi Qiu and Kenda L.J. Evans Agilent Technologies, Inc.…
Key words
payload, payloadbrentuximab, brentuximabsurrogate, surrogatepeptide, peptidevvsvltvlhqdwlngk, vvsvltvlhqdwlngkassaymap, assaymapmonkey, monkeybravo, bravovedotin, vedotinlba, lbaadc, adcquantitative, quantitativeworkflow, workflowtrastuzumab, trastuzumabdrug
Analysis of Antibody-Drug Conjugates Using Size Exclusion Chromatography and Mass Spectrometry
2017|Agilent Technologies|Applications
Analysis of Antibody-Drug Conjugates Using Size Exclusion Chromatography and Mass Spectrometry Application Note Biologics and Biosimilars Author Abstract Sonja Schneider Recombinant monoclonal antibodies (mAbs) have emerged as important Agilent Technologies, Inc. therapeutic agents for the treatment of different diseases. This…
Key words
trastuzumab, trastuzumabadcs, adcsadc, adcemtansine, emtansinedeconvoluted, deconvolutedcounts, countsdrug, drugdeglycosylated, deglycosylatedamu, amusec, secmass, massmabs, mabsspectrum, spectrumbuffer, bufferantibody
Native SEC/MS Analysis of mAbs on an Entirely Biocompatible Flow Path
2023|Agilent Technologies|Applications
Application Note Biopharma/Pharma Native SEC/MS Analysis of mAbs on an Entirely Biocompatible Flow Path Using the Agilent 1290 Infinity II Bio LC System and Agilent AdvanceBio SEC 200 Å 1.9 µm PEEK-lined column in mAbs analysis Authors Abstract Liesa Verscheure,…
Key words
sec, secretention, retentionpeek, peekmin, mincolumn, columnnistmab, nistmabmau, maunative, nativesst, sstbio, biotime, timelined, lineddeconvoluted, deconvolutedresponse, responsehmw